WHO WE ARE
We are a talented group of scientists with a groundbreaking idea for improving patient outcomes in depression. At Genetika+, we believe that each individual is unique, and bringing the right solution for each individual's depression is our priority. Contact us today to hear more about our cutting-edge technologies.
THE TEAM
TALIA COHEN SOLAL,
PhD
CEO & Co-Founder
OXFORD, UCL, COLUMBIA, PAIRNOMIX
DAPHNA LAIFENFELD,
PhD
CSO & Co-Founder
TECHNION, TAU, HARVARD, TEVA, IBEX
NADAV ASKARI,
PhD
CTO
HUJI, SBP, SMART ASSAYS, MERCK
JOSHUA SCHULMAN,
PhD
SVP Partnerships
and Innovation
COLUMBIA, NYU, OMRIX, MAXQ AI
OUR SCIENTIFIC ADVISORY BOARD
MAURIZIO FAVA,
MD
Director of Clinical Research,
Harvard University
STEPHEN M. STAHL
MD, PhD, DSc
Adjunct Professor, Psychiatry
University of San Diego
JESSICA TENEBAUM,
PhD
Assistant Professor,
Duke University
BOARD OF DIRECTORS
SCOTT GAZELLE,
PhD
CHAIRMAN
DARTMOUTH, CWRU,
MGH, HARVARD
TOM MILLER,
MSc
UMASS, MIT,
MGH, ZEISS, SIEMENS
TALIA COHEN SOLAL,
PhD
OXFORD, UCL, COLUMBIA, PAIRNOMIX
DAPHNA LAIFENFELD,
PhD
TECHNION, TAU, HARVARD, TEVA, IBEX
MARK WEISER,
MD
Director of Psychiatry
Sheba Medical Center
ALEXANDER HARRIS,
MD, PhD
Associate Professor,
Columbia University
BARBARA CORNEO,
PhD
Associate Professor,
Columbia University
AWARDS AND RECOGNITION
Winner Extreme Tech Challenge Health Israel, 2021